To evaluate a new valve, the Portico™ NG Transcatheter Aortic Heart Valve, in patients who have symptomatic, severe aortic stenosis and are determined to be at high or extreme surgical risk.
Structural Heart Disease
|Eligibility criteria|| |
To be considered for the study you must meet the following criteria:
|Study details|| |
Your participation in this study would be for approximately 12 months.
You will need to undergo a minimally invasive surgical procedure to have the valve inserted and stay in hospital overnight. You will then be seen in the clinic at 30 days and 12 months post-procedure. During these visits you will be asked about your health, medications, have a physical examination, 6-minute walk test, blood test, an ultrasound of your heart and ECG performed.
Sign up to this clinical trial here.
Prof. Stephen Worthley
MBBS, PhD, FRACP, FACC, FCSANZ, FRCP
Executive Manager - Cardiology
Dr Joseph Montarello
MBBS, FRACP, FCSANZ
Interventional CardiologistWorks at 6 centres.
Dr Anthony Camuglia
MBBS (Monash, Hons1), MHA (Monash), FRACP, FCSANZ
Interventional CardiologistWorks at 3 centres.
Dr Sam Hayman
BSc, MSc, MBBS (Hons), FRACP
Interventional CardiologistWorks at 2 centres.